SHARE PURCHASE AGREEMENT1Share Purchase Agreement • October 18th, 2021 • NeuroSense Therapeutics Ltd. • Pharmaceutical preparations
THIS SHARE PURCHASE AGREEMENT (this “Agreement”), is made as of this [ ] day of [ ], [ ], by and between NeuroSense Therapeutics Ltd., a company registered under the laws of the State of Israel, having its principal place of business at [ ], Israel (the “Company”) and [ ], Israeli I.D. no. [ ], residing at [ ] (the “Investor”).
ContractSafe • October 18th, 2021 • NeuroSense Therapeutics Ltd. • Pharmaceutical preparations
THIS INSTRUMENT AND ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM.
SHARE PURCHASE AGREEMENTShare Purchase Agreement • October 18th, 2021 • NeuroSense Therapeutics Ltd. • Pharmaceutical preparations • Tel-Aviv
THIS SHARE PURCHASE AGREEMENT (this “Agreement”), is made as of this 25 day of February, 2018, by and between NeuroSense Therapeutics Ltd., a company registered under the laws of the State of Israel, having its principal place of business at [ ], Israel (the “Company”), and the investors listed under Exhibit A attached hereto (the “Investors”).
